Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Moderna Stock Looks Too Cheap After This Recent Dip

By Chris Lau, InvestorPlace Contributor

Investors who enjoyed a five-fold return this year are selling now but more upside approaches as Moderna ships vaccines worldwide.

7 Short-Term Stocks To Buy for a Happy New Year  

By Chris Lau, InvestorPlace Contributor

Investors already enjoying strong gains in the year may want to look at these short-term stocks to buy heading into the new year.

Beware of FuelCell Energy, Especially as the Hype Winds Down

By Chris Lau, InvestorPlace Contributor

FCEL stock benefited from the frenzied buying for hydrogen energy suppliers and the green energy bullishness.

Switchback Energy Stock Isn’t a Buy-and-Hold, but Consider Trading the Swings

By Chris Lau, InvestorPlace Contributor

Bearish bets against SBE stock are also growing, setting a duel between bulls and bears and a hot trade ahead.

Why Fisker Has Electrifying Upside Ahead

By Chris Lau, InvestorPlace Contributor

The markets recognize that Fisker stock has potential despite the electric vehicle company's limited resources.

Load More